SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-13-001531
Filing Date
2013-07-30
Accepted
2013-07-29 21:11:33
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 medizone10q063013.htm 10-Q 375656
2 ex31-1.htm EX-31.1 10111
3 ex31-2.htm EX-31.2 10006
4 ex32-1.htm EX-32.1 5460
5 ex32-2.htm EX-32.2 6449
  Complete submission text file 0001185185-13-001531.txt   3555602

Data Files

Seq Description Document Type Size
6 mzei-20130630.xml EX-101.INS 290113
7 mzei-20130630.xsd EX-101.SCH 30979
8 mzei-20130630_cal.xml EX-101.CAL 23259
9 mzei-20130630_def.xml EX-101.DEF 128260
10 mzei-20130630_lab.xml EX-101.LAB 219814
11 mzei-20130630_pre.xml EX-101.PRE 131046
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 13993893
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries